- Home
- RMI vs ORMP Comparison
RMI vs ORMP Comparison
Compare RMI & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMI
- ORMP
- Stock Information
- Founded
- RMI 2018
- ORMP 2002
- Country
- RMI United States
- ORMP United States
- Employees
- RMI N/A
- ORMP N/A
- Industry
- RMI Finance/Investors Services
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- RMI Finance
- ORMP Health Care
- Exchange
- RMI Nasdaq
- ORMP Nasdaq
- Market Cap
- RMI 94.0M
- ORMP 104.6M
- IPO Year
- RMI N/A
- ORMP N/A
- Fundamental
- Price
- RMI $14.52
- ORMP $2.49
- Analyst Decision
- RMI
- ORMP
- Analyst Count
- RMI 0
- ORMP 0
- Target Price
- RMI N/A
- ORMP N/A
- AVG Volume (30 Days)
- RMI 17.4K
- ORMP 167.9K
- Earning Date
- RMI 01-01-0001
- ORMP 11-13-2025
- Dividend Yield
- RMI 7.28%
- ORMP N/A
- EPS Growth
- RMI N/A
- ORMP 838.25
- EPS
- RMI N/A
- ORMP 1.03
- Revenue
- RMI N/A
- ORMP $2,000,000.00
- Revenue This Year
- RMI N/A
- ORMP N/A
- Revenue Next Year
- RMI N/A
- ORMP N/A
- P/E Ratio
- RMI N/A
- ORMP $2.28
- Revenue Growth
- RMI N/A
- ORMP N/A
- 52 Week Low
- RMI $13.05
- ORMP $1.82
- 52 Week High
- RMI $17.37
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- RMI 45.08
- ORMP 62.65
- Support Level
- RMI $14.37
- ORMP $2.25
- Resistance Level
- RMI $14.72
- ORMP $2.49
- Average True Range (ATR)
- RMI 0.14
- ORMP 0.12
- MACD
- RMI -0.02
- ORMP 0.02
- Stochastic Oscillator
- RMI 21.63
- ORMP 82.43
About RMI RiverNorth Opportunistic Municipal Income Fund Inc.
RiverNorth Opportunistic Municipal Income Fund, Inc. is a diversified, closed-end management investment company. Its investment objective is to seek current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.